Public Health Genomics: future paradigm shift for YHC? Prof. dr. Frans J.M. Feron Department of Social Medicine Faculty of Health Medicine and Life Sciences Maastricht University f.feron@maastrichtuniversity.nl Public Health Genomics: • …the use of genomics information to benefit Public Health • …an emerging field of study that assesses the impact of genes and their interaction with behavior, diet and the environment on the population’s health • …18.800.000 hits on ‘Genomics’ by Google • …1.320.000 hits on ‘Public Health Genomics’ by Google • …798.385 ‘genomic’ hits by PubMed FHML - Social Medicine – Prof. dr. F. Feron 2 slide 2 The main focus of Child & Youth Health Care: • …health - growth – development • …the interaction between the genetically biological vulnerable child and the environment where relevant to health – growth - development FHML - Social Medicine – Prof. dr. F. Feron 3 slide 3 The Health Field Concept Marc Lalonde, 1974 FHML - Social Medicine – Prof. dr. F. Feron slide 4 The Health Field Concept Marc Lalonde, 1974 FHML - Social Medicine – Prof. dr. F. Feron slide 5 Bio-ecological transactional model FHML - Social Medicine – Prof. dr. F. Feron slide 6 Bio-ecological transactional model FHML - Social Medicine – Prof. dr. F. Feron slide 7 Biopsychosocial model Ref: Brunner & Marmot, 2006 FHML - Social Medicine – Prof. dr. F. Feron 8 slide 8 Biopsychosocial model Ref: Brunner & Marmot, 2006 FHML - Social Medicine – Prof. dr. F. Feron 9 slide 9 Genomics prospective health care: Ref: Snyderman R. The role of genomics in enabling prospective health care. In: Willard H, Ginsburg GS, eds. Genomic and personalized medicine. Durham, NC: Elsevier, 2009:378–85. FHML - Social Medicine – Prof. dr. F. Feron slide 10 Vanderbilt doing long-term study of child health Dec. 3, 2010, 3:03 a.m. CST Associated Press NASHVILLE, Tenn. (AP) — Vanderbilt University Medical Center in Nashville and others have begun a major long-term study of child health in the United States. The National Children's Study will examine how environment, behavior and genetics impact children's health, development and growth. It will track 100,000 children from before birth to age 21. FHML - Social Medicine – Prof. dr. F. Feron 11 slide 11 Vanderbilt doing long-term study of child health Dec. 3, 2010, 3:03 a.m. CST Associated Press NASHVILLE, Tenn. (AP) — Vanderbilt University Medical Center in Nashville and others have begun a major long-term study of child health in the United States. The National Children's Study will examine how environment, behavior and genetics impact children's health, development and growth. It will track 100,000 children from before birth to age 21. FHML - Social Medicine – Prof. dr. F. Feron 12 slide 12 “Classic” example: newborn screening Aandoening Per jaar (NL) Adrenogenitaal Syndroom (AGS) Biotinidase deficiëntie (BIO) 15-20 2 Congenitale hypothyreoïdie (CH) 70-90 Galactosemie (GAL) 6 Glutaar acidurie type I (GA-I) 1 HMG-CoA-lyase deficiëntie (HMG) ? Homocystinurie (HCY) 1-2 Isovaleriaan acidemie (IVA) 3 Long-chain hydroxyacylCoA dehydrogenase deficiëntie (LCHAD) ? Maple syrup urine disease (MSUD) 1 Medium-chain acylCoA dehydrogenase deficiëntie (MCAD) 3-methylcrotonyl-CoAcarboxylase deficiëntie (3-MCC) Multiple CoA carboxylase deficiëntie (MCD) 15-17 (?) ? Phenylketonurie (PKU) 10-15 Sikkelcelziekte (SZ) 40-60 Thalassemie 25-50 Tyrosinemie type I (TYR-I) 2 Very long-chain acylCoA dehydrogenase deficiëntie (VLCAD) ? Cystic Fibrosis (CF) 50 Totaal per jaar op ca 180.000 FHML - Social Medicine – 240-320 Prof. dr. F. Feron slide 13 “Classic” example: newborn screening Aandoening Per jaar (NL) Adrenogenitaal Syndroom (AGS) Biotinidase deficiëntie (BIO) 15-20 2 Congenitale hypothyreoïdie (CH) 70-90 Galactosemie (GAL) 6 Glutaar acidurie type I (GA-I) 1 HMG-CoA-lyase deficiëntie (HMG) ? Homocystinurie (HCY) 1-2 Isovaleriaan acidemie (IVA) 3 Long-chain hydroxyacylCoA dehydrogenase deficiëntie (LCHAD) ? Maple syrup urine disease (MSUD) 1 Medium-chain acylCoA dehydrogenase deficiëntie (MCAD) 3-methylcrotonyl-CoAcarboxylase deficiëntie (3-MCC) Multiple CoA carboxylase deficiëntie (MCD) 15-17 (?) ? Phenylketonurie (PKU) 10-15 Sikkelcelziekte (SZ) 40-60 Thalassemie 25-50 Tyrosinemie type I (TYR-I) 2 Very long-chain acylCoA dehydrogenase deficiëntie (VLCAD) ? Cystic Fibrosis (CF) 50 Totaal per jaar op ca 180.000 FHML - Social Medicine – 240-320 Prof. dr. F. Feron slide 14 Example: ADHD The totality of evidence indicates that neurological and genetic factors play a substantial role in the origins and the expression of this disorder Russell A. Barkley, 2006 FHML - Social Medicine – Prof. dr. F. Feron 15 slide 15 ADHD: genetic contribution is a “fact in the bag” Evidence-based genetic association with ADHD: DRD4 DRD5 DAT DBH 5-HTT HTR1B SNAP-25 - dopamine D4 receptor dopamine D5 receptor dopamine transporter gen dopamine β-hydroxylase serotonin transporter gen serotonin receptor gen synaptosomal-associated protein 25 Faraone et al, Biol Psychiatry, 2005;57:1313 FHML - Social Medicine – Prof. dr. F. Feron 16 slide 16 Example: schisis FHML - Social Medicine – Prof. dr. F. Feron slide 17 Example: early life stress FHML - Social Medicine – Prof. dr. F. Feron slide 18 Example: Child maltreatment Ref: Nature Neuroscience 2009, vol. 12 no. 8 FHML - Social Medicine – Prof. dr. F. Feron slide 19 Paradigm shift: FHML - Social Medicine – Prof. dr. F. Feron slide 20 FHML - Social Medicine – Prof. dr. F. Feron slide 21 Challenges and benefits PH-Genomics for child and youth health care… • To develop and make family history tools available for prevention • To understand health effects of gene-environment interaction via public health investigations • To improve quality of life for our children & families • To reduce health costs through early detection and intervention • To improve long-term health outcomes in a life course perspective, with children transitioning to healthy and productive adults Child Health Genomics Working Group, Canada 2008 FHML - Social Medicine – Prof. dr. F. Feron 22 slide 22 On behalf of all children… …I wish you lots of (genomics-)inspiration for the future! FHML - Social Medicine – Prof. dr. F. Feron slide 23 Thank you for your attention Maastricht, 2011 - Prof. dr. Frans J.M. Feron